GlassScriptPhysician profile
Katherine H Leary
NPI 1871671792
$7,179.30
in general payments reported to CMS, 2019-2025
40 companies · $54.81 in 2025
The $54.81 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,312 · 2022: $2,226 · 2023: $2,318 · 2024: $268 · 2025: $54.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,639 · Education: $2.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,638.62 |
| Education | $2.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,358.51 | 2021-2024 | |
| Novo Nordisk INC | $996.11 | 2021-2023 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $756.53 | 2021-2023 | Breztri, Farxiga |
| Biohaven Pharmaceutical Holding Company LTD. | $407.52 | 2022 | |
| Glaxosmithkline, LLC. | $383.98 | 2023 | Shingrix, Arexvy, Trelegy Ellipta |
| Medtronic, INC. | $327.87 | 2022 | |
| Astellas Pharma US INC | $283.32 | 2021-2023 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $274.95 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $263.51 | 2021-2023 | Jardiance |
| Lilly USA, LLC | $237.05 | 2021-2024 | Mounjaro, Jardiance, Lyumjev |
| Pfizer INC. | $210.76 | 2021-2024 | |
| Teva Pharmaceuticals USA, INC. | $194.39 | 2021-2022 | |
| Abbott Laboratories | $165.29 | 2021-2024 | Freestyle Libre 3 |
| Biohaven Pharmaceuticals, INC. | $160.54 | 2021 | |
| Nestle Healthcare Nutrition INC. | $154.91 | 2021-2022 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Leary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.